Genome-wide association studies have identified 11 common variants convincingly associated with coronary artery disease (CAD) 1-7 , a modest number considering the apparent heritability of CAD 8 . All of these variants have been discovered in European populations. We report a meta-analysis of four large genome-wide association studies of CAD, with ~575,000 genotyped SNPs in a discovery dataset comprising 15,420 individuals with CAD (cases) (8,424 Europeans and 6,996 South Asians) and 15,062 controls. There was little evidence for ancestry-specific associations, supporting the use of combined analyses. Replication in an independent sample of 21,408 cases and 19,185 controls identified five loci newly associated with CAD (P < 5 × 10 −8 in the combined discovery and replication analysis): LIPA on 10q23, PDGFD on 11q22, ADAMTS7-MORF4L1 on 15q25, a gene rich locus on 7q22 and KIAA1462 on 10p11. The CAD-associated SNP in the PDGFD locus showed tissue-specific cis expression quantitative trait locus effects. These findings implicate new pathways for CAD susceptibility.
Genome-wide association studies (GWAS) in CAD have detected common variants with odds ratios of 1.1-1.3 which in aggregate explain only a small proportion of the predicted genetic risk. We hypothesized that the discovery of new susceptibility loci of smaller effect sizes (and, hence, identification of new CAD-related pathways) would be aided by conducting much larger studies in addition to an emphasis on early onset CAD and clearly defined clinical endpoints.
For the discovery stage, 8,424 cases of European ancestry were recruited by the Precocious Coronary Artery Disease (PROCARDIS) study and Heart Protection Study (HPS), and 6,996 cases of South Asian ancestry (chiefly from Pakistan and India) were recruited by the Pakistan Risk of Myocardial Infarction Study (PROMIS) and London Life Sciences Prospective Population (LOLIPOP) study. All studies recruited controls, or supplemented their data with genotypes from common controls, from within the same self-reported ethnic or linguistic groups from which cases were recruited (Fig. 1) . Overall, 81% of the cases had a prior history of myocardial infarction and the remainder had confirmed diagnoses of symptomatic CAD (angina or coronary artery revascularization), with an average age at first event under 60 years (Supplementary Table 1 ).
All individuals were typed using whole-genome Illumina BeadChips, allowing for a meta-analysis of actual genotypes rather than imputed data. This enabled analysis of low frequency variants (1-5%), which have typically been excluded from GWAS either due to sample size or because imputation has been required to combine data from different genotyping platforms.
As there is population substructure within India and Pakistan 9 , principal component analysis 10 was used in the PROMIS and LOLIPOP studies to identify ancestry informative principal components (Online Methods and Supplementary Fig. 1 ), which were then used to adjust for population substructure in regression analyses.
Genotypes were tested for association with CAD in the four discovery studies (Online Methods and Supplementary Table 2) . Association tests for 574,919 SNPs were entered into pre-specified fixed-effects metaanalyses with study-level correction for genomic control; the meta-analysis groups were: (i) all four studies combined; (ii) the two European studies; and (iii) the two South Asian studies. The genomic control parameters A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease * A full list of authors and affiliations appears at the end of the paper. The Coronary Artery Disease (C4D) Genetics Consortium * l e t t e r s l e t t e r s (λ GC ) after the study-level genomic control correction were 1.03 for the four studies combined, 1.01 for the European studies only and 1.01 for the South Asian studies only; a further meta-analysis-level genomic control correction was applied to each meta-analysis. Heterogeneity was tested between the four discovery GWAS and between the European and South Asian meta-analyses. Manhattan plots are shown in Figure 2 for the meta-analysis of all studies combined and in Supplementary Figure 2 for the ancestry-specific meta-analyses, and the quantile-quantile plots are shown in Supplementary Figure 3 .
We confirmed the power and representative nature of our discovery-stage studies with data supporting the relevance of 11 known CAD susceptibility loci with comparable effect sizes to those reported previously ( Table 1) . We saw directionally consistent effects in the European and South Asian populations for all 11 loci.
We selected 59 SNPs from 50 loci that showed potential new associations from the meta-analysis of the European and South Asian studies (41 SNPs; P < 1.0 × 10 −4 ), the European only meta-analysis (8 SNPs; P < 3.0 × 10 −5 ), the South Asian only meta-analysis (6 SNPS; P < 3.0 × 10 −5 ) and three loci with strong biological plausibility but only suggestive P values (4 SNPs). These SNPs were tested in ten replication studies involving a total of 21,408 CAD cases and 19,185 controls largely by de novo genotyping (Fig. 1) . The meta-analysis of the replication association results is shown in Supplementary  Table 3 . Five SNPs in the newly associated loci achieved the prespecified threshold for replication (P < 8.5 × 10 −4 ; which is P < 0.05 after Bonferroni correction for 59 independent tests), and each also achieved conventional genome-wide significance (P < 5.0 × 10 −8 ), with P values ranging from 2.8 × 10 −13 to 3.9 × 10 −8 for the combined discovery and replication meta-analysis (Fig. 3) . Apparent heterogeneity between the European and South Asian effect for rs4380028 in the ADAMTS7-MORF4L1 locus in the discovery meta-analysis was not supported by the independent replication. We observed no evidence of ancestry-specific heterogeneity for any of the other previously unidentified loci in either the discovery or replication meta-analyses.
In addition to the five newly associated loci, rs9349379, located in an intron of PHACTR1, was significantly associated in the replication alone (P = 9.9 × 10 −10 ) and in the combined discovery and replication (P = 8.7 × 10 −26 ) meta-analyses, and rs17114046, in an intron of PPAP2B, showed consistent support in the discovery and replication meta-analyses but fell outside the pre-determined significance level in both the replication alone (P = 1.1 × 10 −3 ) and in the combined discovery and replication (P = 2.5 × 10 −7 ) metaanalyses. It is plausible that other SNPs in the replication study that had suggestive associations have a real effect on CAD; a quantilequantile plot (Supplementary Fig. 3 ) of the replication study results shows an overdispersion of the test statistic.
The regional association plots for each confirmed locus are shown in Figure 4 . We performed analyses conditioning on the replicated SNP at each new locus in all four discovery studies, and the meta-analysis of these results revealed no evidence of additional independent associations with CAD.
We investigated associations between the expression levels of all genes within 200 kb of each of the confirmed risk SNPs in tissue samples of aortic media and adventitia, mammary artery, carotid plaque, liver, adipose tissue, transformed lymphoblastoid cell lines and skin. The Bonferroni-adjusted significance threshold was P < 3.1 × 10 −4 (P < 0.05 over 163 tests). Estimates of genotype effect on gene expression are reported in Supplementary Table 4 for the most significantly associated gene in each search window and, when different from the risk SNP, the most significant expression quantitative trait locus (eQTL) SNP.
None of these loci has any previously reported associations with established CAD risk factors (lipids, blood pressure, glucometabolic traits or body mass index). rs4380028 in the ADAMTS7-MORF4L1 Odds ratios per risk allele and 95% CIs for 11 SNPs previously associated with CAD 1, [3] [4] [5] [6] [7] 19 are reported in the discovery studies separately and overall. l e t t e r s locus is ~200 kb downstream of a robust QTL for cigarettes smoked per day, but a conditional analysis for cigarettes smoked per day showed no attenuation of the CAD risk (P = 0.38). Inspection of the regional association plots of each locus (Fig. 4) , reinforced by our own or previously published eQTL data, suggests that specific genes can be implicated at two of the new loci (rs1412444 and rs974819).
rs1412444 is in an intron of the LIPA, the lysosomal acid lipase gene. The risk allele of this SNP has been strongly linked with increased expression level of LIPA mRNA in circulating monocytes 11 , was the lead eQTL SNP for LIPA in our data and had suggestive association with increased expression in liver (P < 1.6 × 10 −3 ; Supplementary Table 4) . Loss-of-function alleles in LIPA cause a Mendelian cholesterol ester storage disorder with hypercholesterolaemia and increased atherosclerosis, but rs1412444 is, at most, very weakly associated with LDL cholesterol levels 11 . This suggests that risk is mediated not by interfering with hepatic cholesterol ester hydrolysis (and thereby LDL receptor downregulation) but rather by some other mechanism. Regional plots for significant associations with CAD. Regional association plots of the discovery meta-analysis from which each replicated SNP was selected; that is, the European and South Asian discovery metaanalysis (a,b and d,e) and South Asian metaanalysis (c). Each panel shows SNPs plotted by position on the chromosome against -log 10 P, with estimated recombination rates from HapMap release 27 (CEU, YRI and JPT+CHB populations) plotted in light blue to reflect the Figure 3 Newly identified loci and variants associated with CAD in European, South Asian and all studies. Odds ratios per copy of the risk allele are indicated by squares (size inversely proportional to the variance), with horizontal lines indicating 95% CIs. Odds ratios and 95% CIs for all participants are indicated by diamonds. Allele frequencies (allele freq) are given for the risk allele. P values for heterogeneity between European and South Asian (S Asian) results are reported (ethnic P het ). *The South Asian only discovery P value for rs4380028 was P = 3.6 × 10 −6 .
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The nearest gene to rs974819 is PDGFD, 117 kb downstream in an adjacent block of linkage disequilibrium (LD) (Fig. 4) . We found a significant PDGFD eQTL for rs974819 in aortic media (P < 2.3 × 10 −7 ), with suggestive associations in aortic adventitia (P < 7.7 × 10 −4 ) and mammary artery (P < 7.2 × 10 −4 ) (Supplementary Table 4) . In all three tissues, the risk allele was associated with increased expression, and PDGFD was one of the top 10% most highly expressed transcripts. Platelet-derived growth factor D, encoded by PDGFD, is expressed in several cell types in atherosclerotic plaques and is predicted to stimulate atherosclerosis by influencing matrix metalloproteinase activity and monocyte migration 12 and by inhibiting smooth muscle cell gene expression 13 .
rs4380028 is 7.6 kb upstream of ADAMTS7. ADAMTS7 is a metalloproteinase that accumulates in carotid artery neointima after injury and is upregulated by platelet-derived growth factor 14 . The CAD association at the ADAMTS7 locus appears to be independent of the adjacent QTL for cigarette smoking, which has been attributed to the CHRNA5-CHRNA3-CHRNB4 nicotinic acid receptor cluster 15 . The signal at rs4380028 therefore appears new but cannot be attributed to a specific gene.
At the 7q22 locus, the lead SNP, rs10953541, is within an intron of BCAP29, which encodes B-cell receptor-associated protein 29, but this SNP is also in strong LD with five other protein coding genes (PRKAR2B, HBP1, COG5, GPR22 and DUS4L). We observed no unique eQTL effect. One promising biological candidate is GPR22, which encodes a G-protein-coupled receptor expressed in coronary arteries and heart 16 .
rs2505083 is in an intron of KIAA1462, a widely expressed and evolutionarily conserved gene. The function of the 1,359-amino-acid protein encoded by KIAA1462 is largely unknown, with no recognizable functional domains and little homology to other protein families.
The genetic evidence for rs17114046 in PPAP2B is further supported by the association of the risk allele, with a suggestive (P < 3.9 × 10 −3 ) 30% increase in PPAP2B expression in atherosclerotic plaque (Supplementary Table 4) . PPAP2B encodes phosphatidic acid phosphatase type 2B, a membrane glycoprotein that hydrolyzes bioactive lipids involved in signaling 17 . It is expressed in the adherens junctions of endothelial cells and is believed to influence endothelial cell adhesion and migration and vasculogenesis 18 .
In summary, five new loci passed both the pre-specified significance threshold for the stand-alone replication and the conventional threshold for genome-wide significance in the combined discovery and replication data, yielding a substantial increase in the number of confirmed susceptibility loci for CAD. We did not find any susceptibility variants with material differences in effect size or allele frequency between South Asians and Europeans. We note, however, the potential limitation that current genome-wide arrays may not capture all important variants in South Asians. Nevertheless, all of the known and new variants were significantly associated with CAD risk in both the European and South Asian populations in the current study, indicating the importance of the genes associated with CAD beyond the European ancestry groups in which they were first defined.
As is seen in the present study, the effect sizes of previously unidentified CAD-associated genes discovered by GWAS have become progressively smaller, suggesting that there may not be large-effect common variants remaining to be discovered, but rather that a large number of common variants of small effect may contribute to CAD risk. Reliable detection of differences of only 5-10% in the per-allele risk of CAD has previously been difficult. However, the availability of large-scale GWAS carried out in populations of different ancestry, and our demonstration that results from such populations can be informatively combined in genetic discovery, suggests that even broader collaborations would identify additional variants that influence CAD risk. Greater understanding of the genetic variants underlying CAD, and particularly the pathways involved, may lead to development of new therapeutic approaches to help address the world's leading cause of death. 
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
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Discovery. Cases and controls in the discovery studies. The PROCARDIS study comprised individuals recruited from the UK, Italy, Sweden and Germany 22 . All cases had a diagnosis of CAD before age 66 and 80% had a sibling in whom CAD had been diagnosed before age 66. CAD was defined as clinically documented evidence of myocardial infarction (80%), coronary artery bypass graft (10%), acute coronary syndrome (6%), coronary angioplasty (1%) or stable angina (hospitalization for angina or documented obstructive coronary disease) (3%) before age 66. The mean age of onset of CAD was 53.2 years (standard deviation (s.d.), 7.2 years). The Heart Protection Study (HPS) was a large UK-based cholesterol-lowering trial involving participants with a history of myocardial infarction, unstable or stable angina, coronary artery bypass graft or coronary angioplasty (as well as individuals with prior history of stroke or hypertension) 23 . Among these, 2,704 CAD cases were genotyped and compared with 2,887 controls from the UK 1958 British Birth Cohort. Of those individuals genotyped, the mean age of CAD onset was 58.8 years (s.d., 8.4 years), and 92% of CAD cases had a history of myocardial infarction, revascularization or hospitalization for angina.
The PROMIS study was a case-control study of myocardial infarction carried out among South Asians living in urban Pakistan 24 . The 4,253 cases had myocardial infarction, and the average age of disease onset was 53.8 years (s.d., 10.6 years). The 4,130 controls were matched to cases by sex and age and recruited in the same hospitals as the index cases. The major ethnic groups of the participants in the PROMIS study were as follows: Urdu (42%), Punjabi (28%), Pathan (8%) and Sindhi (8%).
The LOLIPOP study was a case-control study of CAD carried out among South Asians, a population category defined by having all four grandparents born on the Indian subcontinent, living in the UK 25 . The 2,741 cases had a history of myocardial infarction, coronary artery revascularization (coronary artery bypass grafting or percutaneous coronary intervention) or angiographically confirmed coronary artery stenosis greater than 50%. The cases were compared with 3,696 controls, free from CAD, recruited from the same ethnic or linguistic groups. The mean age of entry into the study was 59.3 years (s.d., 9.7 years). For further details of the discovery cohorts, see the Supplementary Note.
Genotyping in the discovery studies. The genotyping platforms, centers and quality control parameters are summarized in Supplementary Table 2 . Additional quality control was done by testing for different allelic frequencies between centers, bead arrays, batches or BeadChips, and a further 3,883 SNPs were removed.
To identify ancestry outliers, principal component analysis using EIGENSOFT (3.0) 10 was used to compare all samples with reference samples from the HapMap YRI, CHB, JPT and CEU panels. Samples with eigenvalues inconsistent with self-reported ancestry were removed. To detect and correct for population stratification, a panel of independent SNPs were used to generate ancestry-informative principal components. South Asian samples were plotted by their self-reported ethnic or linguistic group and case or control status (Supplementary Fig. 1 ).
Ethics. All studies were collected under the approval of the appropriate ethics committee and all participants gave informed consent for each study.
Statistical analyses. Discovery genome-wide analyses.
Association analyses of CAD were carried out after exclusion of SNPs that failed quality control. Analyses were performed using logistic models to estimate regression coefficients and their standard errors. Additive genetic effects were modeled by defining continuous variables with levels 0, 1 and 2 corresponding to genotypes AA, AB and BB. The test statistics for each study were inspected for over-dispersion, and the genomic control parameter (λ GC ), an estimate of the variance inflation, was between 1.03 to 1.08 (Supplementary Table 2 ).
Clustering and covariate adjustment. The multi-center PROCARDIS study included country of origin as a categorical main effect to model differences in SNP allele frequencies indirectly across the populations. The familial relatedness in the PROCARDIS study was taken into account using a robust (sandwich) estimator of the variance. The PROMIS and LOLIPOP studies included ancestry-informative principal components to absorb population stratification.
Discovery meta-analysis. A fixed-effects inverse variance-weighted metaanalysis as implemented by METAL (see URLs) was used to combine the individual studies concurrently as European studies only, South Asian studies only and all studies. The individual studies were subjected to study-level correction for genomic control (using the sample-specific λ GC described above). The test statistics for each meta-analysis were inspected for over-dispersion (Supplementary Fig. 3) . The λ GC of the three meta-analyses were calculated (λ GC = 1.01 Europeans only, λ GC = 1.01 South Asians only and λ GC = 1.03 for all studies), and an additional genomic control correction was applied using these λ GC factors (double genomic control correction). Heterogeneity between the European and the South Asian studies and between all studies was assessed using the Cochran's Q statistic. 33 , and 3,359 cases and 2,828 controls of South Asian ancestry from the PROMIS 24 and INTERHEART 34 studies.
Replication. Cases and controls in the replication
Selection of replication SNPs. SNPs were ranked by the association P value in the discovery meta-analysis. The genotype clusters for all SNPs with an association with CAD of P < 1.0 × 10 −4 were manually checked, and 13 SNPs were removed. With the exception of rs9349379 at the PHACTR1 locus, SNPs that were located within a locus that had been previously reported to be associated with CAD (Table 1) , or SNPs in strong LD (r 2 > 0.5) with the most significant SNP at each locus, were removed. All remaining SNPs with P < 3.0 × 10 −5 in either the European studies only or South Asian studies or with P < 1.0 × 10 −4 in the all-studies meta-analysis were considered for replication. When a SNP could not be multiplexed, alternative tagging SNPs (r 2 > 0.8) were considered.
Genotyping in the replication studies. Genotyping of the replication samples was performed by primer extension and MALDI-TOF mass spectrometry using Sequenom iPLEX technology as two multiplexes containing 59 replication SNPs and three gender-specific polymorphisms. At the Centre National de Génotypage (CNG), the assay for rs9349379 was replaced by a Kaspar SNP assay supplied by KBioscience Ltd. The PROMIS replication genotypes included data from 1,005 Illumina Human660 arrays which were not available during the discovery GWAS. The COROGENE replication genotypes were obtained in silico from Illumina Human670 GWAS data.
The allelic intensities of each SNP assay were plotted and, where necessary, genotypes were manually called. SNPs with genotype calls that deviated from Hardy-Weinberg equilibrium with P < 8.5 × 10 −4 or had minor allele frequency <1% were excluded. The call rate cutoff for SNPs was empirically established in each study. SNP genotypes that passed quality control were used to determine a study-specific sample rate cutoff. Details of replication genotyping and related quality control steps are summarized in Supplementary  Table 2 . The PROCARDIS TDT study was a family based collection, and an additional quality control step was applied whereby families with greater than three Mendelian misinheritances were excluded.
Statistical analyses. Replication analyses.
Logistic regression models were used to perform association analyses of CAD and to estimate the per-allele effect and standard error. The family based transmission disequilibrium test was used to estimate the association in the PROCARDIS TDT samples. This test is robust to the presence of population structure and was performed using TRANSMIT (see URLs) written by David Clayton.
Replication meta-analysis. A fixed-effects inverse-variance-weighted meta-analysis was used to combine the results for each SNP across all replication studies with available data. Heterogeneity between all studies and between the European and the South Asian studies was assessed using Cochran's Q statistic.
Conditional analysis. Conditional analyses were performed in each of the discovery studies. The position of the recombination hotspots flanking each of the SNPs selected for replication was determined, and those SNPs that were located between the two flanking hotspots were tested for association with CAD with the equivalent model used in the discovery analysis but conditioning on the genotype of the SNP chosen for replication. eQTL analyses. Tissue samples for gene expression biobanks were obtained as described previously 35 . Briefly, tissue biopsies were taken from patients undergoing carotid endartectomy (plaque n = 117) or valve surgery (liver n = 152, aorta media n = 117, aorta adventitia n = 103 and mammary artery n = 88). Extracted RNA was hybridized to Affymetrix HG-U133 plus 2.0 microarrays (plaque) or Affymetrix ST 1.0 Exon arrays (liver, aorta and mammary artery), and obtained scans were robust multichip average (RMA) normalized and log2 transformed. DNA was extracted from circulating blood cells and hybridized to Illumina Human610w-Quad Beadarrays. In the MuTHER study, RNA levels were measured in lymphoblastoid cell lines (n = 826), skin (n = 705) and fat biopsies (n = 825) from 850 well-phenotyped female twins (1/3 MZ and 2/3 DZ) from the TwinsUK resource using Illumina's wholegenome expression array HumanHT-12 version 3 as previously described 36 . Genotyping was performed in parallel using Illumina's whole-genome arrays. Associations between genotype and expression of genes were assessed using an additive linear model.
